Patient-Centered NeuroRehabilitation (PCN) for Cognitive Deficit
This study is looking at ways to improve thinking abilities (cognitive abilities) in people aged 50 and older who have cognitive difficulties. These difficulties can come from normal aging, neurodegenerative diseases, or other conditions. Researchers are testing two main approaches: cognitive rehabilitation, which uses methods to improve everyday tasks, and transcranial electrical stimulation (TES). TES involves using small amounts of electricity on the scalp to try and change how the brain works. You might receive active TES (tDCS or tACS), sham (inactive) TES, or a cognitively based intervention, or a combination. The goal is to find the best ways to use these methods to help with attention, learning, memory, finding words, and problem-solving.
- Study design
- This interventional study plans to enroll 500 participants aged 50 and older. It uses a crossover design, meaning some participants may receive both active and sham (inactive) treatments.
- What's involved
- Participants may receive up to 260 sessions of active or sham transcranial electrical stimulation (tDCS or tACS) and/or a cognitively based intervention. Side effects will be measured immediately after TES sessions.
- Compensation
- Not stated in the trial record.
- Follow-up
- Side effects are measured immediately after TES sessions. The record does not specify long-term follow-up after treatment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Patient-Centered NeuroRehabilitation (PCN)
At a glance
Conditions
NCT03036319
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
University of Michigan - Department of Psychiatry
Ann Arbor, Michiganstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Benjamin M Hampstead, Ph.D. · PRINCIPAL_INVESTIGATOR · University of Michigan
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- TES side effect questionnaireImmediately following TES (<15 minutes)
Side effect questionnaire that asks participants to rate the severity of potential TES related side effects